Ryoji Maekura
Overview
Explore the profile of Ryoji Maekura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
666
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miki M, Miki K, Akiba E, Kagawa H, Oshitani Y, Matsuki T, et al.
BMC Pulm Med
. 2024 Apr;
24(1):210.
PMID: 38684989
Background: Measurement of exhaled nitric oxide (FeNO) is a potentially useful diagnostic test for asthma. However, no study has explored the relationship between FeNO and respiratory symptoms of nontuberculous mycobacterial...
2.
Tateishi Y, Ozeki Y, Nishiyama A, Miki M, Maekura R, Kida H, et al.
BMC Microbiol
. 2023 Apr;
23(1):94.
PMID: 37009882
Background: Mycobacterium intracellulare is a major etiological agent of Mycobacterium avium-intracellulare pulmonary disease (MAC-PD). However, the characteristics of the virulence of M. intracellulare and the in vivo chemotherapeutic efficacy remain...
3.
Maekura R, Miki K, Tateishi Y, Matsumoto S, Kitada S, Miki M, et al.
Microbiol Spectr
. 2022 Apr;
10(3):e0053022.
PMID: 35467367
Clinical characteristics and outcomes of multidrug chemotherapy have been used as the main prognostic factors for Mycobacterium avium-intracellulare complex pulmonary disease (MAC-PD) over the last decade; however, no useful prognostic...
4.
Miyazaki A, Miki K, Maekura R, Tsujino K, Hashimoto H, Miki M, et al.
J Clin Med
. 2022 Feb;
11(4).
PMID: 35207235
Background: In cardiopulmonary exercise testing (CPET), oxygen uptake () is calculated using the product of minute ventilation () and the difference between inspiratory and expiratory O concentrations (ΔFO). However, little...
5.
Kawasaki T, Kitada S, Fukushima K, Akiba E, Haduki K, Saito H, et al.
Microbiol Spectr
. 2022 Jan;
10(1):e0140621.
PMID: 34985326
Although serum anti-glycopeptidolipid (GPL)-core IgA antibody is a highly specific test for infection with Mycobacterium avium complex (MAC), Mycobacterium abscessus, and its subspecies , subsp. , and subsp. (MAB), its...
6.
Miki K, Tsujino K, Maekura R, Matsuki T, Miki M, Hashimoto H, et al.
Front Physiol
. 2021 Oct;
12:770151.
PMID: 34658937
[This corrects the article DOI: 10.3389/fphys.2021.703977.].
7.
Ohara Y, Ozeki Y, Tateishi Y, Mashima T, Arisaka F, Tsunaka Y, et al.
PLoS One
. 2021 Aug;
16(8):e0256946.
PMID: 34449816
[This corrects the article DOI: 10.1371/journal.pone.0204160.].
8.
Miki K, Tsujino K, Maekura R, Matsuki T, Miki M, Hashimoto H, et al.
Front Physiol
. 2021 Aug;
12:703977.
PMID: 34393822
In contrast to cardiovascular disease, low rather than high ventilatory inefficiency, evaluated by the minute ventilation-carbon dioxide output (-)-slope, has been recognized as being related to greater disease severity in...
9.
Tateishi Y, Ozeki Y, Nishiyama A, Miki M, Maekura R, Fukushima Y, et al.
BMC Microbiol
. 2021 Apr;
21(1):103.
PMID: 33823816
Background: Mycobacterium intracellulare is a representative etiological agent of emerging pulmonary M. avium-intracellulare complex disease in the industrialized countries worldwide. The recent genome sequencing of clinical strains isolated from pulmonary...
10.
Maekura T, Miki K, Miki M, Kitada S, Maekura R
Int J Chron Obstruct Pulmon Dis
. 2019 Dec;
14:2787-2798.
PMID: 31827322
Purpose: Pharmacological therapy and pulmonary rehabilitation are useful for exertional dyspnoea in patients with chronic obstructive pulmonary disease (COPD); however, several patients have no meaningful improvements. Although acupuncture significantly improves...